文献速递脊柱关节炎

银屑病关节炎的家族聚集性:有与无银屑病家族史患者的表型差异

Familial Aggregation in Psoriatic Arthritis: Phenotypic Differences in Patients With and Without a Family History of Psoriatic Disease.
PubMed 文献 · Arthritis Rheumatol · 2025-09-21

该研究纳入843例银屑病关节炎(PsA)患者,45.0%有至少一名一级或二级亲属患银屑病性疾病。有家族史者银屑病和PsA发病均更早,且附着点受累比例更高;一级或二级亲属患PsA者发病早于亲属仅患银屑病者,后者又早于无家族史者。

要点

  • 45.0%(379例)的PsA患者有至少一名一级或二级亲属患银屑病性疾病。
  • 有家族史者银屑病平均发病27.6岁 vs 无家族史32.2岁(P < 0.01),PsA平均37.6岁 vs 40.3岁(P < 0.01)。
  • 有家族史者附着点受累36.7% vs 无家族史30.0%(P < 0.05)。

核心结论

  • 在该队列中,有银屑病性疾病家族史的PsA患者银屑病和PsA诊断更早,且更可能伴有附着点受累。
  • 作者提出需进一步研究纳入分子和免疫特征,以探讨影响PsA表型、严重程度及银屑病向PsA转变的遗传、环境和表观遗传因素。

研究设计与样本

  • 观察性纵向注册研究,共纳入843例银屑病关节炎(PsA)患者,收集人口学、病史、家族史及银屑病表型和活动度资料。

主要发现

  • 379例(45.0%)患者有至少一名一级或二级亲属患银屑病性疾病。
  • 有家族史者银屑病平均发病年龄27.6岁 vs 无家族史者32.2岁(P < 0.01)。
  • 有家族史者PsA平均发病年龄37.6岁 vs 无家族史者40.3岁(P < 0.01)。
  • 有家族史者附着点受累比例36.7% vs 无家族史者30.0%(P < 0.05)。
  • 一级或二级亲属患PsA、亲属仅患银屑病、无家族史三组银屑病平均发病年龄分别为26.3岁、27.8岁、32.2岁(P < 0.01),PsA平均发病年龄分别为36.5岁、37.9岁、40.3岁(P = 0.01)。

局限性

  • 作者指出需进一步研究纳入分子和免疫特征,以探讨影响PsA表型、严重程度及银屑病向PsA转变的遗传、环境和表观遗传因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although up to 45% of patients with psoriatic arthritis (PsA) have a family history of psoriatic disease, it is unclear whether this family history contributes to a distinct PsA phenotype and/or the timing of disease onset. We aimed to identify differences in onset, domain involvement, and disease activity based on family history of psoriatic disease. METHODS: A total of 843 patients with PsA were enrolled in an observational, longitudinal registry. Demographics, medical history, family history, and psoriatic phenotype and activity were collected. RESULTS: Of the total, 379 patients (45.0%) had at least one first-degree relative (FDR) or second-degree relative (SDR) with psoriatic disease. Those with a family history developed psoriasis and PsA earlier than those with no family history (psoriasis: mean 27.6 vs 32.2 years [P < 0.01]; PsA: mean 37.6 years vs 40.3 years [P < 0.01]) and were more likely to have entheseal involvement (36.7% vs 30.0%; P < 0.05). Patients with an FDR or SDR with PsA were diagnosed with psoriasis and PsA earlier than those with an FDR or SDR with psoriasis alone, followed by those with no family history (psoriasis: mean 26.3 vs 27.8 vs 32.2 years, respectively [P < 0.01]; PsA: mean 36.5 vs 37.9 vs 40.3 years, respectively [P = 0.01]). CONCLUSION: In this cohort, patients with PsA with a family history of psoriatic disease were diagnosed with psoriasis and PsA earlier and were more likely to have entheseal involvement compared to those without a family history. Further research incorporating molecular and immune features is needed to investigate genetic, environmental, and epigenetic factors that impact PsA phenotype and severity, as well as the transition from psoriasis to PsA.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Howe C, Hu J, Chen W, et al. Familial Aggregation in Psoriatic Arthritis: Phenotypic Differences in Patients With and Without a Family History of Psoriatic Disease. Arthritis Rheumatol. 2025. PMID: 40977175. doi:10.1002/art.43325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。